Table 2.

Normalized cumulative dose around patients in each period of time post ¹³¹I administration (μSv·MBq⁻¹).

Group	Distance	Period of Time Post 131I Administration
		0–6 h	6–12 h	12–18 h	18–24 h	24–30 h	30–36 h	36–42 h	42–48 h	48–54 h	54–60 h	60–66 h	66–72 h
group (A)	1 m	0.25763	0.15540	0.10409	0.07081	0.04827	0.03292	0.02245	0.01531	0.01044	0.00712	0.00485	0.00331
	1.5 m	0.12358	0.07414	0.05059	0.03452	0.02356	0.01607	0.01097	0.00748	0.00511	0.00348	0.00238	0.00162
	2 m	0.07074	0.04256	0.02899	0.01974	0.01345	0.00916	0.00624	0.00425	0.00289	0.00197	0.00134	0.00091
	3 m	0.03272	0.01942	0.01303	0.00874	0.00587	0.00394	0.00264	0.00177	0.00119	0.00080	0.00054	0.00036
group (FU)	1 m	0.23573	0.14137	0.09405	0.06408	0.04387	0.03007	0.02062	0.01413	0.00969	0.00665	0.00456	0.00312
	1.5 m	0.10692	0.06805	0.04596	0.03108	0.02102	0.01421	0.00961	0.00650	0.00440	0.00297	0.00201	0.00136
	2 m	0.06280	0.03941	0.02622	0.01789	0.01232	0.00852	0.00591	0.00409	0.00284	0.00197	0.00137	0.00095
	3 m	0.02903	0.01854	0.01220	0.00822	0.00565	0.00394	0.00278	0.00197	0.00141	0.00101	0.00073	0.00052